Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Agouron Pharmaceuticals (AGPH) -- Ignore unavailable to you. Want to Upgrade?

To: Izzy who wrote (4169)	4/27/1998 9:51:00 PM
From: Oliver & Co	Read Replies (1) \| Respond to of 6136

From Microsoft Investor: Advisor ÿ Top alerts for Agouron Pharmaceuticals, Inc. From 4/17/98 to 4/20/98: The three-month relative price strength rating for AGPH was at least 20 percentage points above its 12 month relative strength. Learn More. See a Historical Chart On 4/14/98: It was reported that AGPH beat average analyst earnings estimates. Learn More. See Earnings Surprise Research alerts for Agouron Pharmaceuticals, Inc. On 4/27/98: Analysis of the most recent financial results for AGPH shows that the company's income per employee has been at least 10% above its industry average. Learn More. See Management Efficiency On 4/20/98: It was reported that institutional holdings of AGPH have increased by 5% or more. This data is generally updated in Investor monthly. Such an increase is generally considered bullish for a stock because it tends to mean greater price stability and stature. Learn More. See Business Profile Overview Since 4/20/98: Analysis shows that the price-to-sales ratio (PSR) of AGPH has been at least 25% below its industry's average. A PSR significantly below the industry average is one tool sometimes used to begin a search for undervalued stocks. Learn More. See Price Ratios Since 4/16/98: Analysis showed that the price to cash flow ratio of AGPH has been at least 25% below its industry average. Learn More. See Price Ratios